You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • THU0354 Disease worsening and safety in patients switching from originator infliximab to biosimilar infliximab (CT-P13) in the randomized nor-switch-study: explorative analysis in SPA patients

Article metrics

Article menu

Download PDFPDF

Poster Presentations
Spondyloarthritis - treatment
THU0354 Disease worsening and safety in patients switching from originator infliximab to biosimilar infliximab (CT-P13) in the randomized nor-switch-study: explorative analysis in SPA patients
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to August 2024

AbstractFullPdf
Jun 20175102
Jul 20175603
Aug 20173005
Sep 20173402
Oct 20176203
Nov 20175601
Dec 20173800
Jan 20182804
Feb 20184800
Mar 20183801
Apr 20181800
May 20181201
Jun 20182601
Jul 2018800
Aug 201817800
Sep 201823405
Oct 201825802
Nov 201817002
Dec 201814202
Jan 20199002
Feb 20192501
Mar 20192803
Apr 201918903
May 20195803
Jun 20198401
Jul 2019803
Aug 20192704
Sep 20194802
Oct 20192904
Nov 20194006
Dec 20191201
Jan 20201001
Feb 2020703
Mar 2020401
May 20201402
Jun 2020600
Jul 20202202
Aug 20201203
Sep 20202801
Oct 20203601
Nov 2020702
Dec 20201602
Jan 2021803
Feb 2021301
Mar 2021603
Apr 2021204
May 2021102
Jul 2021001
Aug 2021004
Sep 2021104
Oct 20212015
Nov 20219010
Dec 20211103
Jan 2022200
Feb 2022200
Mar 2022403
May 2022806
Jun 20221204
Jul 20221400
Aug 20222004
Sep 2022209
Oct 2022403
Nov 20221402
Dec 2022201
Jan 2023603
Feb 2023401
Mar 20231001
Apr 20231000
May 2023002
Jul 2023203
Aug 2023001
Sep 2023801
Oct 20234002
Nov 20233001
Dec 20233801
Jan 20245400
Feb 20243001
Mar 20242408
Apr 20242401
May 20242000
Jun 20242004
Jul 20243701
Aug 20242402
Total27950200